NRC
NRC Health
20.20$
+0.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +19.3% | +2.8% | -43.6% | +38.8% | -32.3% | +4.2% | -117.1% | – | -47.8% | +0.0% | -80.7% | – | |
| – | -8.0% | +1.2% | +4.6% | +2.2% | -1.9% | +1.7% | +13.0% | +26.0% | -2.3% | +1.1% | -2.2% | – | |
| – | +279.4% | -114.0% | – | – | -0.5% | -9.0% | +79.5% | +201.3% | +106.4% | -15.8% | +358.4% | – | |
| – | +425.4% | +210.4% | -122.2% | – | -178.1% | – | – | – | -121.0% | – | -2,092.7% | – | |
| – | -15.7% | +9.8% | +27.4% | -69.7% | +178.4% | -32.8% | +0.8% | +19.2% | -68.8% | +63.6% | -27.8% | – | |
| – | -15.7% | +9.8% | +27.4% | +22.0% | -30.9% | -32.8% | +0.8% | +19.2% | -68.8% | +63.6% | -27.8% | – | |
| – | -89.3% | -1.4% | -1.4% | -0.1% | -1.6% | -1.7% | -1.3% | +1.5% | -2.8% | +34.4% | -0.5% | – | |
| – | +4,754.0% | +0.0% | -100.0% | – | -13.5% | -33.5% | +21.7% | +54.7% | -100.0% | +193,400.0% | +295.0% | – | |
| – | – | – | – | – | -20.8% | -72.3% | +526.5% | -106.0% | +8.9% | +0.0% | – | – | |
| – | -78.7% | +151.4% | -78.8% | -99.4% | +6,741.2% | +363.5% | – | -291.2% | -68.7% | +67.7% | – | – | |
| – | – | -275.4% | – | – | -74.1% | -324.2% | – | -210.2% | – | -182.9% | – | – | |
| – | +48.5% | -0.5% | -80.8% | +415.9% | -75.3% | +89.1% | -213.4% | – | -40.5% | -11.8% | -98.8% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.